Raptiva (efalizumab)

efalizumab · Genentech, a Roche company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Raptiva (efalizumab), covering 2012-01-19 to 2016-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Efalizumab in the Treatment of Alopecia, Phase II [Phase 2]